Skip to search formSkip to main contentSkip to account menu

9-hydroxyellipticine

Known as: NSC 210717 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryMicrobial transformation of cytotoxic 5,11-dimethyl-5H-indolo[2,3-b]quinoline (a compound displaying antitumor activity… 
1987
1987
Evidences for the formation of the glutathione-hydroxyellipticine adduct during the rat metabolism of 9-methoxyellipticine are… 
1983
1983
In aqueous solution and using molecular oxygen as electron acceptor, the antitumor drug 9-hydroxyellipticine (9-OH-E) undergoes a… 
1983
1983
Incubation with 9-hydroxyellipticine (9-OH-E) decreases the survival of X-irradiated CHO cells. The survival decreases in the… 
1982
1982
Administration of a single dose of the inhibitor of the hepatic mixed function oxidases, 9-hydroxyellipticine (9-OHE), resulted… 
Review
1981
Review
1981
Ellipticine, 5,11-dimethyl-(6H)-pyrido-(4,3,b)-carbazole (NSC 71795) is a potent cytotoxic and antitumor agent. Several of its… 
1981
1981
The effects of some inducers of microsomal cytochrome P450-dependent monooxygenases on the metabolic bioactivation and the… 
1980
1980
The kinetoplast DNA (kDNA) of cultured Trypanosoma cruzi consists mostly in a large network of numerous minicircular molecules… 
1976
1976
The antitumor activity of a new derivative of ellipticine, 9-hydroxyellipticine (NSC 210717), was studied using L1210 mouse… 
1976
1976
Ethidium bromide, an intercalating drug, was shown to inhibit the in vitro DNA binding of the uterine estradiol-receptor complex…